Last updated on December 2018

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis


Brief description of study

The purpose of this study is to assess the efficacy and safety of ruxolitinib cream in adolescents and adults with atopic dermatitis (AD).

Clinical Study Identifier: NCT03745651

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center (US)

Well Pharma Medical Research Corporation
Miami, FL United States
8.18miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.